Bruker Corp (BRKR) | Finance information

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to

Market

Industry

Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares.	$11.4 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt.	$12 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price.	$0.20 (0.26%)
1 Year Return Profit or loss of share price change plus dividend yield.	+15.4%
52-Week High Highest share price in the last 52 weeks.	$78.94
52-Week Low Lowest share price in the last 52 weeks.	$48.35
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return.	1.06
Outstanding Shares The number of shares the company has issued and are held by stockholders.	147 Million
Avg 30 Day Volume The number of shares traded in the last 30 days.	796 Thousand

Valuation

Compare to

Market

Industry

P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth.	38.44
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued.	134.09
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value.	$1.99
Price to Sales Ratio Market cap divided by the revenue in the most recent year.	4.64
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company	11.26
Enterprise Value to Revenue Enterprise value divided by revenue	4.73
Enterprise Value to EBIT Enterprise Value divided by EBIT	25.89
Total Debt to Enterprise Value Total debt divided by enterprise value	0.1
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary.	1.09

Profitability

Compare to

Market

Industry

Revenue Revenue is the sum of all cash flow into the company.	$2.53 Billion
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services.	$1.31 Billion
EBIT Earnings before tax and interest payments.	$463 Million
Net Income Net Income is the profit after all expenses have been deducted from the total revenue.	$297 Million
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability.	11.72%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago.	+28.7%
Return on Equity Equity divided by market cap.	26.63%
Return on Assets Indicates a company's profitability in relation to its total assets.	8.21%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits.	17.15%

Insider trades

Q3 2022 Q4 2022 Q1 2023 Q2 2023

About Bruker Corp

CEO: Frank Laukien

Employees: 6,000

Industry: Analytical Laboratory Instrument Manufacturing

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with its customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

Similar stocks

Perkinelmer, Inc.

Thermo Fisher Scientific Inc.

Waters Corp.

Bio-Rad Laboratories Inc. - Class A

Agilent Technologies Inc.

Illumina Inc

Accelerate Diagnostics Inc

Danaher Corp.

Ametek Inc

General Electric Co.

News

Bruker nabs two 1.2 GHz NMR systems orders from the U.K.

Bruker (BRKR) is expanding its fundamental research infrastructure with recent orders for two 1.2 GHz Avance nuclear magnetic resonance spectrometers for the...

Seeking Alpha, 15 days ago

Bruker Corporation to Present at Investor Conferences

BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will ...

Business Wire, about 1 month ago

Bruker Announces Quarterly Dividend

Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per sh...

Wallstreet:Online, about 1 month ago